Stockholm, Sweden – Barnik Invest Group, an investment firm dedicated to pioneering the advancement of innovative life science companies in the Nordics, today announced the formation of Barnik Holdings AB. This new holding company will serve as the umbrella entity for all Barnik Invest Group portfolio companies.
Barnik Holdings AB will offer investors the opportunity to diversify their investments by accessing a portfolio of promising life science companies. Investors can choose to invest in all portfolio companies through Barnik Holdings AB, enabling risk diversification, or select individual companies for targeted investments. Additionally, Barnik Holdings AB will provide investment opportunities in the company’s pipeline of promising life science ventures.
“The creation of Barnik Holdings AB is a significant milestone for Barnik Invest Group,” said Hamid Bakhshi, CEO of Barnik Invest Group. “This new structure will enhance our ability to attract investors and provide them with more efficient and diversified investment experience.”
For more information, please contact;
Hamid Bakhshi, CEO
Telephone: +46738531165
E-mail: hamid.bakhshi@barnikinvest.com
About Barnik Invest Group
Barnik Invest Group is a leading 360 solution partner for small Life Science companies in the Nordics. The company provides a comprehensive suite of services to support its portfolio companies, including capital, clinical development, expertise, and commercialization. Through its fully-owned subsidiaries, Medicorent and StartUpPharma, Barnik Invest offers CRO services, outsourcing, recruitment, distribution, product development and commercialization solutions. Barnik’s mission is to nurture promising life science companies from early clinical development phase to commercialization, enabling them to achieve positive cash flows or successful exits and ultimately enhancing patient well-being and improving human health worldwide. For more information visit www.barnikinvest.com.
